|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Gain on Lease termination | |||||
| Impairment of long-lived assets | |||||
| Impairment of goodwill | |||||
| Loss on extinguishment of debt | |||||
| Amortization of deferred financing costs | |||||
| Stock-based compensation | |||||
| Provision for inventory write-down | |||||
| Provision for credit losses, net of recoveries | |||||
| Provision for sales returns | |||||
| Provision for warranty | |||||
| Provision for warranty expense | |||||
| Unrealized loss on foreign currency transactions | |||||
| Subsidiary dissolution | |||||
| Loss (gain) of disposal of property, plant and equipment | |||||
| Deferred taxes | |||||
| Changes in operating assets and liabilities excluding effects of acquisition: | |||||
| Accounts receivable | |||||
| Other receivable | |||||
| Inventories | |||||
| Contract assets | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Contract liabilities | |||||
| Accrued and other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from disposal of property, plant and equipment and other assets | |||||
| Purchases of property, plant and equipment | |||||
| Acquisition of business, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock in public offerings, net of issuance costs | |||||
| Proceeds from long-term borrowings | |||||
| Repayments of long-term borrowings | |||||
| Proceeds from short-term borrowings and line of credit, net | |||||
| Repayments of short-term borrowings and line of credit, net | |||||
| Proceeds from related party term loan | |||||
| Repayments of related party term loan | |||||
| Payments for debt financing costs | |||||
| Payment of contingent consideration | |||||
| Proceeds from exercise of stock awards and employee stock plan purchases | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid during the period for: | |||||
| Interest - bank and trade facilities | |||||
| Interest - related party | |||||
| Income taxes | |||||
| Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Long-term restricted cash | |||||
Loading...